US Patent 10351553 Potassium channel modulators
Patent 10351553 was granted and assigned to Cadent Therapeutics on July, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+60 characters)
Article
Patent abstract
Provided herein are compounds of the formula:
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Dipak Vasantrao Amrutkar0
Gregg F. Keaney0
Janus Schreiber Larsen0
Karin Sandager Nielsen0
Kelly Foster0
Martin R. Jefson0
Thomas Amos Jacobsen0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103515530
Date of Patent
July 16, 2019
0Patent Application Number
159382920
Date Filed
March 28, 2018
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 5 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 27 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10351553 Potassium channel modulators
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10351553
Date of patent
July 16, 2019
Patent application number
15938292
Date Filed
March 28, 2018
Patent primary examiner
Find more entities like US Patent 10351553 Potassium channel modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
